i think this one a little different..., page-56

Sure the focus of the moment is on the wild swings in the daily movements. After this market frenzy subsides something with much longer market potential will remain. The day traders will have won or lost and the real value of VLA will be sorted out. (Not that I don't do a bit of day trading. I do)
"Dr Mark Smithers, principle investigator for the study, from the Princess Alexandra Hospital, Brisbane, said: A successful completion to this study was very important. We have now established a safety profile that allows the product to advance to Phase II efficacy evaluation. Cavatak offers to be an exciting alternative in the attempt to establish successful immune therapy of Melanoma. Immune therapy, I believe, will play a significant role in the future treatment of this disease.